Company Filing History:
Years Active: 2020-2023
Title: Ranit Kedmi: Innovator in Targeted Therapeutics
Introduction
Ranit Kedmi is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of targeted therapeutics, holding a total of 3 patents. His work focuses on innovative pharmaceutical compositions that enhance the efficacy of treatments.
Latest Patents
Kedmi's latest patents include a modular platform for targeted therapeutics, which discloses a lipidated secondary antibody. This invention also encompasses particles comprising the same. Another notable patent is related to immunoparticles and methods of generating and using them. This pharmaceutical composition features an immunoparticle that includes a monoclonal secondary antibody immunocomplexed with a primary antibody. The monoclonal secondary antibody is coupled on the outer surface of a particle, which is loaded with a pharmaceutical agent.
Career Highlights
Ranit Kedmi is associated with Ramot at Tel Aviv University Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on therapeutic applications.
Collaborations
Kedmi collaborates with notable colleagues, including Dan Peer and Nuphar Veiga, who contribute to his research endeavors.
Conclusion
Ranit Kedmi's innovative work in targeted therapeutics exemplifies the potential of modern pharmaceutical research. His contributions are paving the way for more effective treatment options in the medical field.